Australia markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.93-1.98 (-9.47%)
At close: 04:00PM EDT
18.70 -0.23 (-1.22%)
After hours: 06:06PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/11/2023
30/11/2022
30/11/2021
30/11/2020
30/11/2019
Assets
Current assets
Cash
Cash and cash equivalents
54,627
64,474
80,506
119,356
-
Other short-term investments
233,281
244,667
215,214
161,792
-
Total cash
287,908
309,141
295,720
281,148
-
Net receivables
-
0
6,000
0
-
Other current assets
7,595
9,308
9,194
5,940
-
Total current assets
295,503
318,449
311,118
298,434
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
74,199
49,178
40,224
19,855
-
Accumulated depreciation
-26,249
-19,670
-14,879
-13,183
-
Net property, plant and equipment
47,950
29,508
25,345
6,672
-
Equity and other investments
7,421
63,879
137,189
90,890
-
Other long-term assets
4,724
4,923
3,119
347
-
Total non-current assets
60,095
98,310
165,653
97,909
-
Total assets
355,598
416,759
476,771
396,343
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,401
5,064
6,650
3,412
-
Accrued liabilities
8,886
7,676
4,961
1,829
-
Deferred revenues
48,098
37,633
41,212
32,799
-
Other current liabilities
751
1,503
659
700
-
Total current liabilities
86,958
70,655
66,258
44,539
-
Non-current liabilities
Deferred revenues
45,022
35,974
59,022
60,685
-
Other long-term liabilities
-
-
-
850
1,737
Total non-current liabilities
68,147
42,408
68,211
61,535
-
Total liabilities
155,105
113,063
134,469
106,074
-
Stockholders' equity
Common stock
49
47
45
39
-
Retained earnings
-545,200
-401,252
-220,892
-103,698
-
Accumulated other comprehensive income
-655
-4,319
-608
87
-
Total stockholders' equity
200,493
303,696
342,302
290,269
-
Total liabilities and stockholders' equity
355,598
416,759
476,771
396,343
-